Hospitals are no longer chasing volume—they're chasing complexity
In a world reshaped by conflict and political fracture, India's major hospital chains have discovered that disruption, met with ingenuity, can become a catalyst for reinvention. Despite fewer international patients arriving from West Asia and Bangladesh in FY26, companies like Fortis, Apollo, and Max reported revenue growth of 18 to 41 percent by pursuing higher-complexity procedures and opening new corridors into Africa, Central Asia, and Southeast Asia. The lesson embedded in these numbers is an old one: those who build their foundations on a single relationship are always one crisis away from collapse, while those who diversify find resilience where others find ruin.
- West Asia conflict and Bangladesh political unrest grounded flights and severed patient pipelines that Indian hospitals had depended on for years.
- Fortis saw international patient volumes fall nearly 7 percent in a single month, yet the industry's revenue paradoxically surged — because hospitals stopped counting patients and started counting complexity.
- Bangladesh, once the source of roughly three-quarters of India's medical tourists, effectively withdrew from the relationship in 2025, forcing an urgent and wholesale rerouting of business strategy.
- Hospital chains are aggressively courting patients from Iraq, Kenya, Uganda, Uzbekistan, and the Maldives, while investing in digital outreach and facilitator networks to build new pipelines fast.
- Industry leaders project continued FY27 growth but are candid: geopolitical stability remains the variable no balance sheet can fully hedge against.
India's hospital industry has turned geopolitical turbulence into an unlikely growth story. In the fiscal year ending March 2026, major chains reported strong medical tourism revenue gains even as the number of international patients declined — a paradox explained by a deliberate pivot toward high-value, complex procedures like organ transplants, cancer treatment, and robotic surgeries, which command far better margins than routine care.
The disruptions were real. The West Asia conflict grounded flights and stranded patients mid-booking. Bangladesh, which had accounted for roughly three-quarters of India's foreign patient base as recently as 2024, effectively pulled back as bilateral tensions rose in 2025. Fortis felt the volume drop sharply in a single month, yet still grew its medical value tourism revenue by 18.5 percent year-on-year. Max Healthcare, Medanta, and Aster DM Healthcare reported similarly robust results, with Aster's Kerala operations growing medical tourism revenue by 51 percent on the strength of Maldivian arrivals.
The recovery was not passive. Hospitals invested in digital marketing, deepened ties with facilitators in new regions, and built patient pipelines across Africa, the CIS countries, and Southeast Asia. Fortis now draws patients from Kenya, Tanzania, Ethiopia, Uganda, and Uzbekistan. Apollo has deliberately reoriented toward African and Southeast Asian markets. The industry has internalized a hard lesson: geographic concentration is a structural vulnerability.
Looking into FY27, executives remain cautiously optimistic. They acknowledge that sustained momentum depends on geopolitical conditions no hospital can control, but they are betting that diversification and digital engagement will carry them through whatever instability comes next. The hospitals that thrive, it seems, will be those capable of following patients wherever the world still allows them to travel.
India's hospital industry is learning to navigate geopolitical turbulence by chasing higher-value patients across new borders. Despite fewer international patients walking through their doors in the past year, major hospital chains reported surprisingly strong revenue growth from medical tourism in the fiscal year ending March 2026—a counterintuitive result that reveals how hospitals are adapting to a world made less stable by conflict and political upheaval.
The West Asia conflict and political unrest in Bangladesh created immediate friction. When fighting erupted, flights were grounded, and patients who had booked procedures found themselves stranded or unable to travel. Fortis Healthcare, one of India's largest hospital operators, saw its international patient flow drop roughly 7 percent in a single month as the disruptions took hold. Yet the company's overall medical value tourism revenue climbed 18.5 percent year-on-year, reaching ₹639 crore in FY26 from ₹539 crore the previous year. Max Healthcare and Medanta reported similarly robust growth. The arithmetic works because hospitals are no longer chasing volume—they're chasing complexity and cost. International patients increasingly arrive seeking intricate procedures: heart surgeries, cancer treatment, organ transplants, robotic surgeries. These cases command higher fees and better margins than routine care.
Bangladesh had been India's dominant source of medical tourists, accounting for roughly three-quarters of all foreign patients seeking treatment in India as recently as 2024. That relationship fractured in 2025 as bilateral tensions rose, forcing hospital chains to urgently rebuild their patient pipelines elsewhere. Fortis now draws patients from Iraq, Uzbekistan, Kenya, Tanzania, Ethiopia, and Uganda. Apollo Hospitals has deliberately shifted its focus toward Africa, Southeast Asia, and parts of West Asia beyond the conflict zone. Aster DM Healthcare's Kerala operations grew medical tourism revenue by 51 percent, buoyed by increased arrivals from Maldives even as West Asian numbers softened. The hospitals are not simply accepting loss—they are actively rewiring their business models.
These shifts did not happen by accident. Hospital chains have invested in digital marketing, strengthened partnerships with medical tourism facilitators in new regions, and upgraded their infrastructure to attract patients seeking world-class quaternary care. A Gurugram-based hospital executive noted that enhanced brand visibility and online engagement have been critical to offsetting weakness in traditional markets. The strategy appears to be working: companies report that while new patient registrations from West Asia may decline if the conflict persists, the current flow of established patients remains relatively stable.
Looking ahead to the next fiscal year, hospital executives project continued growth, though with caveats. Fortis's chief operating officer acknowledged that geopolitical stability in key markets remains a prerequisite for sustained momentum. Max Healthcare's leadership noted that while West Asian volumes may remain pressured, resilience in emerging markets—particularly in Africa, the Commonwealth of Independent States, and Southeast Asia—should drive overall growth. Aster's deputy managing director emphasized the importance of platform diversification. Even Medanta's leadership, while expressing confidence that West Asian challenges will eventually ease and Bangladesh will return as a market, is clearly hedging its bets by building strength elsewhere. The Indian hospital industry has learned that relying on any single geography is a vulnerability. The next phase of growth will belong to those hospitals that can serve patients wherever they are, and wherever geopolitics allows them to travel.
Citações Notáveis
During the initial period of the conflict, the hospital largely catered to patients who had already travelled and were present in India, resulting in a drop of around 7 percent for the month— Anil Vinayak, Group Chief Operating Officer, Fortis Healthcare
The international business is expected to regain momentum during FY27, subject to geopolitical stability in key markets— Anil Vinayak, Fortis Healthcare
A Conversa do Hearth Outra perspectiva sobre a história
How do hospitals grow revenue when fewer patients are actually coming through the door?
They're treating different patients—ones who need more complex, expensive procedures. A heart transplant generates far more revenue than a routine checkup, even if you're seeing fewer total people.
So the conflict actually forced them to be more selective?
Not exactly selective by choice. The disruptions—grounded flights, travel fears—naturally filtered out patients seeking routine care. What remained were people desperate enough or sick enough to travel anyway, often for serious conditions.
Bangladesh was three-quarters of their business. That's a massive dependency. How did they pivot so quickly?
They didn't pivot overnight. But they'd already been building relationships in Africa and Southeast Asia. The crisis just accelerated what was probably inevitable—no smart business relies on a single market, especially one as politically volatile as South Asia.
Are they actually confident about next year, or is that just executive optimism?
There's real hedging in their language. They say growth will continue "subject to geopolitical stability." That's not confidence—that's a conditional bet. They're building in Africa and the CIS because they know West Asia and Bangladesh are unpredictable.
What does a patient from Kenya or Uganda actually get that they couldn't get at home?
Access to specialized expertise and infrastructure at a fraction of what it costs in the West. India's hospitals have world-class oncology and transplant programs. For a patient in East Africa, it's often the only realistic option.
So geopolitics is reshaping global healthcare?
It's reshaping where healthcare happens. Patients follow stability and access. Right now, that's pointing away from West Asia and toward India's hospitals in ways it wasn't before.